Abdominal Aortic Aneurysm Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Merck Serono, AstraZeneca, Medtronic, RSPR Pharma AB

DelveInsight’s “Abdominal Aortic Aneurysm Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Abdominal Aortic Aneurysm, historical and forecasted epidemiology as well as the Abdominal Aortic Aneurysm market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Abdominal Aortic Aneurysm market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Abdominal Aortic Aneurysm Market Forecast

Some of the key facts of the Abdominal Aortic Aneurysm Market Report: 

• The Abdominal Aortic Aneurysm market size was valued approximately USD 1.5 billion in 2021 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
• The estimated number of diagnosed abdominal aortic aneurysms in the 7MM was 1,641,380 cases in 2021, and this number is projected to rise during the study period [2019-2032]
• The US is predicted to have the greatest number of diagnosed prevalent cases of Abdominal Aortic Aneurysm (752, 408) out of all the 7MM countries in 2021
• With 8,773 cases in 2021, the US had the highest prevalence of ABDOMINAL AORTIC ANEURYSM among 7MM
• The total prevalence of abdominal aortic aneurysms across the EU-5 nations is highest in Germany (192,532), followed by France (138,193), and lowest in Italy (68,202)
• Abdominal aortic aneurysm prevalence in Japan was estimated to be 253,883 cases overall in 2021, and it is anticipated to decline during the prediction period [2023-2032]
• According to the SVS Guidelines, 2% to 8% of those over 60 are affected by abdominal aortic aneurysms. After age 55 for men and after age 70 for women, the prevalence rises quickly
• Abdominal aortic aneurysms (AAAs) are identified in 200,000 Americans each year
• Key Abdominal Aortic Aneurysm Companies: Merck Serono, AstraZeneca, Medtronic, RSPR Pharma AB, Endologix LLC, Cardinal Health, Cook Medical, W. L. Gore & Associates, Inc., MicroPort Scientific Corporation, Artivion Inc, Lifetech Scientific (Shenzhen) Co., Ltd., Lombard Medical, Endologix LLC, Latecba SA, Nectero Medical, Cardiatis SA, Hangzhou Endonom Medtech Co., Ltd, and others
• Key Abdominal Aortic Aneurysm Therapies: Metformin Glucophage, Ticagrelor, Telmisartan, CRD007, and others
• The Abdominal Aortic Aneurysm epidemiology based on gender analyzed that Abdominal aortic aneurysms are more common in men
• The Abdominal Aortic Aneurysm market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Abdominal Aortic Aneurysm pipeline products will significantly revolutionize the Abdominal Aortic Aneurysm market dynamics.

Abdominal Aortic Aneurysm Overview

A localized abdominal aortic aneurysm (AAA) is when the aorta’s diameter is greater than 3 cm or more than 50% larger than normal. It happens when atherosclerosis or plaque buildup weakens the abdominal aorta’s walls, causing them to inflate outward. It takes time to develop and has few observable symptoms.

Get a Free sample for the Abdominal Aortic Aneurysm Market Report 

https://www.delveinsight.com/report-store/abdominal-aortic-aneurysm-market

Abdominal Aortic Aneurysm Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Abdominal Aortic Aneurysm Epidemiology Segmentation:

The Abdominal Aortic Aneurysm market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

• Total Prevalence of Abdominal Aortic Aneurysm
• Prevalent Cases of Abdominal Aortic Aneurysm by severity
• Gender-specific Prevalence of Abdominal Aortic Aneurysm
• Diagnosed Cases of Episodic and Chronic Abdominal Aortic Aneurysm

Download the report to understand which factors are driving Abdominal Aortic Aneurysm epidemiology trends @ Abdominal Aortic Aneurysm Epidemiology Forecast

Abdominal Aortic Aneurysm Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Abdominal Aortic Aneurysm market or expected to get launched during the study period. The analysis covers Abdominal Aortic Aneurysm market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Abdominal Aortic Aneurysm Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Abdominal Aortic Aneurysm Therapies and Key Companies

• Metformin Glucophage: Merck Serono
• Ticagrelor: AstraZeneca
• Telmisartan: Medtronic
• CRD007: RSPR Pharma AB

Discover more about therapies set to grab major Abdominal Aortic Aneurysm market share @ Abdominal Aortic Aneurysm Treatment Market

Scope of the Abdominal Aortic Aneurysm Market Report

• Study Period: 2019–2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Abdominal Aortic Aneurysm Companies: Merck Serono, AstraZeneca, Medtronic, RSPR Pharma AB, Endologix LLC, Cardinal Health, Cook Medical, W. L. Gore & Associates, Inc., MicroPort Scientific Corporation, Artivion Inc, Lifetech Scientific (Shenzhen) Co., Ltd., Lombard Medical, Endologix LLC, Latecba SA, Nectero Medical, Cardiatis SA, Hangzhou Endonom Medtech Co., Ltd, and others
• Key Abdominal Aortic Aneurysm Therapies: Metformin Glucophage, Ticagrelor, Telmisartan, CRD007, and others
• Abdominal Aortic Aneurysm Therapeutic Assessment: Abdominal Aortic Aneurysm current marketed and Abdominal Aortic Aneurysm emerging therapies
• Abdominal Aortic Aneurysm Market Dynamics: Abdominal Aortic Aneurysm market drivers and Abdominal Aortic Aneurysm market barriers 
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
• Abdominal Aortic Aneurysm Unmet Needs, KOL’s views, Analyst’s views, Abdominal Aortic Aneurysm Market Access and Reimbursement 

To know more about Abdominal Aortic Aneurysm companies working in the treatment market, visit @ Abdominal Aortic Aneurysm Clinical Trials and Therapeutic Assessment

Table of Contents 

1. Abdominal Aortic Aneurysm Market Report Introduction

2. Executive Summary for Abdominal Aortic Aneurysm

3. SWOT analysis of Abdominal Aortic Aneurysm

4. Abdominal Aortic Aneurysm Patient Share (%) Overview at a Glance

5. Abdominal Aortic Aneurysm Market Overview at a Glance

6. Abdominal Aortic Aneurysm Disease Background and Overview

7. Abdominal Aortic Aneurysm Epidemiology and Patient Population

8. Country-Specific Patient Population of Abdominal Aortic Aneurysm 

9. Abdominal Aortic Aneurysm Current Treatment and Medical Practices

10. Abdominal Aortic Aneurysm Unmet Needs

11. Abdominal Aortic Aneurysm Emerging Therapies

12. Abdominal Aortic Aneurysm Market Outlook

13. Country-Wise Abdominal Aortic Aneurysm Market Analysis (2019–2032)

14. Abdominal Aortic Aneurysm Market Access and Reimbursement of Therapies

15. Abdominal Aortic Aneurysm Market Drivers

16. Abdominal Aortic Aneurysm Market Barriers

17.  Abdominal Aortic Aneurysm Appendix

18. Abdominal Aortic Aneurysm Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight 

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email: Send Email
Phone: 8774225362
Address:27 Drydock Ave S. Jones Blvd #2432
City: Boston
State: MA
Country: United States
Website: https://www.delveinsight.com/consulting/asset-prioritizaton-services